Conference Coverage

New BACE1 study launches in the shadow of verubecestat’s demise

Publish date: November 4, 2017

 

AT CTAD

On Twitter @Alz_Gal

Pages

Recommended Reading

Cognitive decline not seen with lower BP treatment targets
MDedge Family Medicine
Fueling the Alzheimer’s brain with fat
MDedge Family Medicine
Study linked H2 receptor antagonists, but not PPIs, to dementia
MDedge Family Medicine
Higher BP targets suggested for elderly, cognitively impaired
MDedge Family Medicine
Personality changes may not occur before Alzheimer’s onset
MDedge Family Medicine
APOE affects tau pathology independent of amyloid-beta
MDedge Family Medicine
VIDEO: Alzheimer’s blood test expected soon
MDedge Family Medicine
AF patients without oral anticoagulation face higher dementia risk
MDedge Family Medicine
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
MDedge Family Medicine
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
MDedge Family Medicine